For the specific inhibition of CMA, namely the interaction with HSPA8, a peptide called P140 was discovered a few years ago, successfully undergoing clinical trials for the treatment of systemic lupus erythematosus [48], which may represent a promising therapeutic option in the future. The gene discussed is HSPA8; the disease is systemic lupus erythematosus.